SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): January 3, 1994
---------------
Cephalon, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant specified in Charter)
Delaware 0-19119 23-2484489
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employee
jurisdiction of File Number) Identification No.)
incorporation)
145 Brandywine Parkway
West Chester, PA 19380
- --------------------------------------------------------------------------------
(Address of principal executive offices) Zip Code
REGISTRANT'S TELEPHONE, INCLUDING AREA CODE: 610-344-0200
- --------------------------------------------------------------------------------
(Former name and former address, if changed since last report)
ITEM 5. OTHER EVENTS
------------
The purpose of this Form 8-K is to re-file (i) Amendment No. 2 to License
Agreement dated January 3, 1994 between the Registrant and Laboratoire L. Lafon
and (ii) Amendment No. 2 to Trademark Agreement dated August 23, 1995 between
the Registrant and Genelco S.A. to reinstate portions of the exhibits that were
redacted in the previous filing.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
---------------------------------
(a) Financial Statements.
None.
(b) Pro Forma Financial Information.
None.
(c) Exhibits.
99.1 Amendment No. 2 to License Agreement dated January 3, 1994
between Cephalon, Inc. and Laboratoire L. Lafon.
99.2 Amendment No. 2 to Trademark Agreement dated August 23,
1995 between Cephalon, Inc. and Genelco S.A.
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CEPHALON, INC.
Date: August 3, 1999 By: /s/ J. Kevin Buchi
---------------------------------------------
J. Kevin Buchi
Senior Vice President and Chief
Financial Officer
Exhibit Index
-------------
Exhibit Page
------- ----
99.1 Amendment No. 2 to License Agreement dated January 3, 1994
between Cephalon, Inc. and Laboratoire L. Lafon.
99.2 Amendment No. 2 to Trademark Agreement dated August 23, 1995
between Cephalon, Inc. and Genelco S.A.